Editas Medicine Inc (EDIT) – 2016 Finally Sees First U.S. IPO VC-backed IPO activity in the U.S. is expected to stay low in 2016. The markets are volatile, oil prices are dragging down stocks and fears of overly frothy private valuations pervade. Many recent IPOs have underperformed, even after their terms were revised in many cases, adding to the wariness of investors looking to cash in on their investment and take a company public. When the dust settled on 2015, the markets were down almost across the board, with the NASDAQ eeking up just 5.7%, after double-digit increases in each of the past three…
Editas Medicine Inc (EDIT) – 2016 Finally Sees First U.S. IPO
Guest Post
If you are interested in contributing to ValueWalk on a regular or one time basis read this post http://www.valuewalk.com/guest-posts-hedge-fund-letters/ We do not accept any outside posts or even ads on penny stocks, ICOs, cryptos, forex, binary options and related products.